BCRX
BioCryst Pharmaceuticals Inc.
$8.47
+$0.18(+2.17%)
51
Overall
60
Value
45
Tech
50
Quality
Market Cap
$2.23B
Volume
4.00M
52W Range
$6.00 - $11.31
Target Price
$21.30
EPS Estimates Overview
| Current Quarter | $0.14 | Next Quarter | $0.03 |
| Current Year | $-2.66 | Next Year | $0.32 |
| QoQ Growth | -78.6% | YoY Growth | +112.0% |
| 3Y EPS CAGR | +43.4% | Target Price | $21.30 |
| Consensus | Buy | Upside | +151.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCRX | $8.47 | +2.2% | 4.00M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioCryst Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW